Document is current
Any future updates will be listed below
-
Authors
Luan, Jingyi
Seth, Anushree
Gupta, Rohit https://orcid.org/0000-0001-7570-7527
Wang, Zheyu
Rathi, Priya
Cao, Sisi
Gholami Derami, Hamed
Tang, Rui https://orcid.org/0000-0002-2734-1003
Xu, Baogang
Achilefu, Samuel https://orcid.org/0000-0002-3133-6717
Morrissey, Jeremiah J.
Singamaneni, Srikanth https://orcid.org/0000-0002-7203-2613
-
Funding
Funding for this research was provided by:
National Science Foundation (CBET-1900277)
U.S. Department of Health & Human Services | National Institutes of Health (RO1DE027098, RO1CA141521)
Foundation for Barnes-Jewish Hospital (3706)
- License Information
-
More Information
Article History
Received: 16 January 2019
Accepted: 9 March 2020
First Online: 20 April 2020
Competing interests
: J.L., J.J.M. and S.S. are inventors on a provisional patent related to this technology. The technology has been licensed by the Office of Technology Management at Washington University in St. Louis to Auragent Bioscience LLC, which is developing plasmonic-fluor products. J.L., J.J.M. and S.S. are co-founders/shareholders of Auragent Bioscience LLC. These potential conflicts of interest have been disclosed and are being managed by Washington University in St. Louis. The remaining authors declare no competing interests.
